Collaborator:Resources - Revision history

Tkapur at 10:32, 25 April 2012

2012-04-25T10:32:56Z

Tkapur at 00:53, 19 October 2011

2011-10-19T00:53:54Z

Tkapur at 00:49, 19 October 2011

2011-10-19T00:49:28Z

Tkapur at 00:48, 19 October 2011

2011-10-19T00:48:59Z

Tkapur at 00:45, 19 October 2011

2011-10-19T00:45:40Z

Kikinis at 16:12, 2 March 2010

2010-03-02T16:12:25Z

Kikinis at 16:12, 2 March 2010

2010-03-02T16:12:00Z

Kikinis at 16:10, 2 March 2010

2010-03-02T16:10:09Z

Kikinis at 16:07, 2 March 2010

2010-03-02T16:07:52Z

Kikinis at 16:06, 2 March 2010

2010-03-02T16:06:20Z

@@ Line 10: / Line 10: @@
 Please [mailto:kikinis@bwh.harvard.edu contact us] if you are interested in a collaborative project with NA-MIC.
-*In addition to contacting the center, you are encouraged to contact the NIH Program Officer XXX (NIBIB) or the Lead Science Officer Michael Ackermann, Ph.D. (NLM) for NA-MIC.
+*In addition to contacting the center, you are encouraged to contact the NIH Program Officer Vinay Pai, Ph.D. (NIBIB) or the Lead Science Officer Michael Ackermann, Ph.D. (NLM) for NA-MIC.
 '''Please note key dates:'''  [http://grants1.nih.gov/grants/funding/submissionschedule.htm standard NIH submission dates] for R01s apply to this grant.

@@ Line 6: / Line 6: @@
 *The following PAR is available for funding collaborative research with NCBCs:
-**http://grants.nih.gov/grants/guide/pa-files/PAR-12-001.html (R01) (active)
+**http://grants.nih.gov/grants/guide/pa-files/PAR-12-001.html (R01) (active January 2012-2015)
 Please [mailto:kikinis@bwh.harvard.edu contact us] if you are interested in a collaborative project with NA-MIC.

@@ Line 18: / Line 18: @@
 **New structure: (page 108 of the pdf version)
 ***1 page specific aims
-***6/12 pages for '''Research Strategy'''
+***12 pages for '''Research Strategy'''
 ***(a) '''Significance''':
 ****Explain the importance of the problem or critical barrier to progress in the field that the proposed project addresses.

@@ Line 6: / Line 6: @@
 *The following PAR is available for funding collaborative research with NCBCs:
-**http://grants.nih.gov/grants/guide/pa-files/PAR-08-183.html  (R21)
+**http://grants.nih.gov/grants/guide/pa-files/PAR-12-001.html (R01) (active)
 Please [mailto:kikinis@bwh.harvard.edu contact us] if you are interested in a collaborative project with NA-MIC.
-*In addition to contacting the center, you are encouraged to contact the NIH Program Officer Zohara Cohen, Ph.D. (NIBIB) or the Lead Science Officer Michael Ackermann, Ph.D. (NLM) for NA-MIC.
+*In addition to contacting the center, you are encouraged to contact the NIH Program Officer XXX (NIBIB) or the Lead Science Officer Michael Ackermann, Ph.D. (NLM) for NA-MIC.
-'''Please note key dates:''' Opening Date: September 5, 2008. After that, all [http://grants1.nih.gov/grants/funding/submissionschedule.htm standard NIH submission dates] for R21s and R01s apply to this grant.
+'''Please note key dates:'''  [http://grants1.nih.gov/grants/funding/submissionschedule.htm standard NIH submission dates] for R01s apply to this grant.
 *Notes 2010-03:

@@ Line 7: / Line 7: @@
 *The following PAR is available for funding collaborative research with NCBCs:
 **http://grants.nih.gov/grants/guide/pa-files/PAR-08-183.html  (R21)
-**http://grants.nih.gov/grants/guide/pa-files/PAR-08-184.html  (R01)
+**http://grants.nih.gov/grants/guide/pa-files/PAR-12-001.html (R01)
 Please [mailto:kikinis@bwh.harvard.edu contact us] if you are interested in a collaborative project with NA-MIC.

@@ Line 33: / Line 33: @@
 ****If the project is in the early stages of development, describeany strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.
 ****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.
-***'''Preliminary Studies''' for New Applications: For new applications, include information on Preliminary Studies as part of the Approach section.
+****'''Preliminary Studies''' for New Applications: For new applications, include information on Preliminary Studies as part of the Approach section.
-***'''Progress Report for Renewal and Revision Applications:'''For renewal/revision applications, provide a Progress Report as part of the Approach section. Provide the beginning and ending dates for the period covered since the last competitive review. Summarize the specific aims of the previous project period and the importance of the findings, and emphasize the progress made toward their achievement.
+****'''Progress Report for Renewal and Revision Applications:'''For renewal/revision applications, provide a Progress Report as part of the Approach section. Provide the beginning and ending dates for the period covered since the last competitive review. Summarize the specific aims of the previous project period and the importance of the findings, and emphasize the progress made toward their achievement.

@@ Line 19: / Line 19: @@
 **New structure: (page 108 of the pdf version)
 ***1 page specific aims
-***6/12 pages for research strategy
+***6/12 pages for '''Research Strategy'''
-***(a) Significance:
+***(a) '''Significance''':
 ****Explain the importance of the problem or critical barrier to progress in the field that the proposed project addresses.
 ****Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields.
 ****Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.
-***(b) Innovation
+***(b) '''Innovation'''
 ****Explain how the application challenges and seeks to shift current research or clinical practice paradigms.
 ****Describe any novel theoretical concepts, approaches or methodologies, instrumentation or interventions to be developed or used, and any advantage over existing methodologies, instrumentation, or interventions.
 ****Explain any refinements, improvements, or new applications of theoretical concepts, approaches or methodologies, instrumentation, or interventions.
-***(c) Approach
+***(c) '''Approach'''
 ****Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Unless addressed separately in Item 15 (Resource Sharing Plan), include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate.
 ****Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims.

← Older revision		Revision as of 16:10, 2 March 2010
Line 34:		Line 34:
	****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.		****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.
	***'''Preliminary Studies''' for New Applications: For new applications, include information on Preliminary Studies as part of the Approach section.		***'''Preliminary Studies''' for New Applications: For new applications, include information on Preliminary Studies as part of the Approach section.
		+	***'''Progress Report for Renewal and Revision Applications:'''For renewal/revision applications, provide a Progress Report as part of the Approach section. Provide the beginning and ending dates for the period covered since the last competitive review. Summarize the specific aims of the previous project period and the importance of the findings, and emphasize the progress made toward their achievement.

← Older revision		Revision as of 16:07, 2 March 2010
Line 33:		Line 33:
	****If the project is in the early stages of development, describeany strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.		****If the project is in the early stages of development, describeany strategy to establish feasibility, and address the management of any high risk aspects of the proposed work.
	****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.		****Point any procedures, situations, or materials that may behazardous to personnel and precautions to be exercised. A full discussion on the use of Select Agents should appear in Item 11, below.
		+	***'''Preliminary Studies''' for New Applications: For new applications, include information on Preliminary Studies as part of the Approach section.